Safety and feasibility of outpatient chimeric antigen receptor (CAR) T-cell therapy: experience from a tertiary care center

被引:30
|
作者
Borogovac, Azra [1 ]
Keruakous, Amany [1 ,2 ]
Bycko, Michelle [1 ]
Holter Chakrabarty, Jennifer [1 ]
Ibrahimi, Sami [1 ]
Khawandanah, Mohamad [1 ]
Selby, George B. [1 ]
Yuen, Carrie [1 ]
Schmidt, Sarah [1 ]
Autry, Marcus T. [1 ]
Al-Juhaishi, Taha [1 ]
Wieduwilt, Matthew J. [1 ]
Asch, Adam S. [1 ]
机构
[1] Univ Oklahoma, Hematol Oncol Sect, Dept Med, Hlth Sci Ctr, Oklahoma City, OK 73019 USA
[2] Univ Augusta, Hematol Oncol Sect, Dept Med, Augusta, GA USA
关键词
D O I
10.1038/s41409-022-01664-z
中图分类号
Q6 [生物物理学];
学科分类号
071011 ;
摘要
引用
下载
收藏
页码:1025 / 1027
页数:3
相关论文
共 50 条
  • [41] Chimeric Antigen Receptor (CAR) T Cell Therapy for Glioblastoma
    Lisa Feldman
    Christine Brown
    Behnam Badie
    NeuroMolecular Medicine, 2022, 24 : 35 - 40
  • [42] Integrated Palliative Care for Patients Referred for Chimeric Antigen Receptor (CAR) T-Cell Therapy: A Service Evaluation
    Williams, Rebekah
    Droney, Joanne
    Nicholson, Emma
    Gonzalez, Carlos
    Ellard, Rose
    Bradley, Nathalie
    Maycock, Celvin
    Halley, Angela
    JOURNAL OF PAIN AND SYMPTOM MANAGEMENT, 2024, 67 (02) : e157 - e159
  • [43] Chimeric Antigen Receptor T-Cell Therapy: Reach to Solid Tumor Experience
    Metzinger, Matthew N.
    Verghese, Cherian
    Hamouda, Danae M.
    Lenhard, Amanda
    Choucair, Khalil
    Senzer, Neil
    Brunicardi, F. Charles
    Dworkin, Lance
    Nemunaitis, John
    ONCOLOGY, 2019, 97 (02) : 59 - 74
  • [44] Safety profile of chimeric antigen receptor T-cell immunotherapies (CAR-T) in clinical practice
    Bonaldo, Giulia
    Montanaro, Nicola
    Vaccheri, Alberto
    Motola, Domenico
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2021, 77 (08) : 1225 - 1234
  • [45] Safety profile of chimeric antigen receptor T-cell immunotherapies (CAR-T) in clinical practice
    Giulia Bonaldo
    Nicola Montanaro
    Domenico AlbertoVaccheri
    European Journal of Clinical Pharmacology, 2021, 77 : 1225 - 1234
  • [46] Chimeric antigen receptor T-cell therapy for melanoma
    Razavi, Azadehsadat
    Keshavarz-Fathi, Mahsa
    Pawelek, John
    Rezaei, Nima
    EXPERT REVIEW OF CLINICAL IMMUNOLOGY, 2021, 17 (03) : 209 - 223
  • [47] Chimeric antigen receptor T-cell therapy for ALL
    Maude, Shannon L.
    Shpall, Elizabeth J.
    Grupp, Stephan A.
    HEMATOLOGY-AMERICAN SOCIETY OF HEMATOLOGY EDUCATION PROGRAM, 2014, : 559 - 564
  • [48] Chimeric Antigen Receptor T-Cell Therapy and Hematopoiesis
    Reinhardt, Bryanna
    Lee, Patrick
    Sasine, Joshua P. P.
    CELLS, 2023, 12 (04)
  • [49] Chimeric Antigen Receptor T-Cell Therapy for Glioblastoma
    Ma, Kun
    Hu, Ping
    CANCERS, 2023, 15 (23)
  • [50] Chimeric antigen receptor T-cell therapy toxicities
    Greenbaum, Uri
    Kebriaei, Partow
    Srour, Samer A.
    Olson, Amanda
    Bashir, Qaiser
    Neelapu, Sattva S.
    Rezvani, Katayoun
    Shpall, Elizabeth J.
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2021, 87 (06) : 2414 - 2424